InpharmD

Atlanta, United States Founded: 2014 • Age: 12 yrs
Evidence-based drug information is provided to healthcare providers online.

About InpharmD

InpharmD is a company based in Atlanta (United States) founded in 2014. InpharmD has raised $6.63 million across 2 funding rounds from investors including 645 Ventures, Atlanta Ventures and Y Combinator. InpharmD operates in a competitive market with competitors including Fullscript, Omega Therapeutics, PharMerica, BiomeSense and BAMF Health, among others.

Key Metrics
  • Total Equity Funding
    $6.63M (USD)

    in 2 rounds

  • Latest Funding Round
    $6.5M (USD), Seed

    Dec 2023

  • Investors

Apps and channels of InpharmD

InpharmD publishes 2 mobile apps with over 100 downloads.

InpharmD
Google Play Medical Everyone Free
Developer: InpharmD, LLC
View on Google Play
InpharmD
App Store Medical 17+
Developer: InpharmD
View on App Store

Funding Insights of InpharmD

InpharmD has successfully raised a total of $6.63M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $6.5 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $6.63M
  • Total Rounds 2
  • Last Round Seed β€” $6.5M
  • First Round $125,000

    (Jun 2021)

  • Investors Count 5

All 2 funding rounds of InpharmD with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2023$6.5MSeed–645 Ventures
Jun 2021$125,000Seed–Y Combinator
–
Valuation history

5 investors in total: 5 institutional.

Investors in InpharmD

InpharmD has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include 645 Ventures, Atlanta Ventures and Y Combinator.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
US focused seed and early-stage VC firm
–645ventures.comNew York, United States
Venture capital fund and accelerator focused on startups
–atlantaventures.comAtlanta, United States
Early-stage startups are accelerated via funding and educational programs.
–ycombinator.comMountain View, United States
Offers quality improvement, fraud prevention, and data analytics services in healthcare.
1973qlarant.comEaston, United States
A community for engineering leaders is facilitated by ELC.
–sfelc.comSan Francisco, United States
Premium access

Investor details for InpharmD

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of InpharmD

1 people are tracked at InpharmD (1 in leadership).

NameRoleGroup
Chris W.
Adviser to the CEOLeadership
Premium access

Complete people profiles for InpharmD

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of InpharmD

3 dated milestones of InpharmD across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded InpharmD is founded.
  2. Funding First funding round of $125K.
  3. Funding Latest funding round, Seed, of $6.5M.

Competitors of InpharmD

InpharmD operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fullscript, Omega Therapeutics, PharMerica, BiomeSense and BAMF Health, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
fullscript.com1995Ottawa, Canada$265M251
Supplements dispensing platform is provided for health practitioners.
omegatherapeutics.com2016Cambridge, United States$211M93
Platform for human genome study is provided for precision medicine.
pharmerica.com1998Louisville, United States–4,088
Pharmacy needs of nursing facilities and dispensing software are served.
biomesense.com2018Chicago, United States$8.43M9
AI-enabled platform for microbiome data generation and analysis is developed.
bamfhealth.com2018Grand Rapids, United States$4M25
AI-enabled molecular imaging and theranostics for disease diagnostics are developed.
lifeomic.com2016Indianapolis, United States–111
Storage, management and analysis of omic data for health applications
cuezen.com2021Seattle, United States$5.2M–
AI-powered personalization engine for health behavior change is provided.
coriell.com2013Camden, United States$10.07M–
Provider of precision medicine tools for clinicians
4dmedvision.com2017Hangzhou, China––
AI and cloud-based precision diagnosis tools for healthcare are developed.
Premium access

Detailed competitors of InpharmD

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of InpharmD

The website of InpharmD (inpharmd.com) receives about 25.7K visits a month and ranks #1,005,752 among all websites worldwide, #1,707 in Pharmacy.

  • Monthly visits
    25.7K

    ▲ 11.5% vs previous month

  • Unique visitors
    6.9K

    per month

  • Global rank
    #1,005,752

    among all websites

  • Category rank
    #1,707

    Health · Pharmacy

Similar websites

Websites whose visitors overlap most with InpharmD. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
uspharmacist.com
uspharmacist.com
100%
–#182,856–
wmjonline.org
wmjonline.org
85%
–#1,668,843–
icer.org
icer.org
69%
–#732,386–
primaltrust.org
primaltrust.org
60%
–#582,981–
kch.nhs.uk
60%
426.4K#113,974View details

Latest news on Inpharmd

Premium access

Complete news archive for InpharmD

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to InpharmD

10 companies that operate in the same segment as InpharmD (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts
2016Bengaluru, Karnataka, IndiaUSD 713.57 M––
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M––
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M233
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M––
Tech-enabled mental health solutions for employers are provided.
2016New York, New York, United StatesUSD 508.73 M––
App-based health insurance is offered to individuals and businesses.
2016Paris, FranceUSD 863.12 M––
Virtual care programs for managing chronic diseases are provided.
2011San Francisco, California, United StatesUSD 450.12 MUSD 260.21 M–
AI-driven EMR and practice management software is delivered for clinics.
2010Boca Raton, Florida, United StatesUSD 329.17 M––
Cloud-based administrative tools for healthcare providers are offered.
1997Watertown, United StatesUSD 40 M––
Membership-based primary care platform is offered for employees and consumers.
2007San Francisco, California, United StatesUSD 402.56 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about InpharmD

InpharmD was founded in 2014 and raised its 1st funding round 7 years after it was founded.

InpharmD is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.

InpharmD is a funded company, having raised a total of $6.63M across 2 funding rounds to date. The company's 1st funding round was a Seed of $125K, raised on Jun 2021.

InpharmD was founded in 2014 in Atlanta, United States, within the healthcare technology sector. A digital platform is operated for providers decision support, where medication-related questions are submitted via website or app. Customized, evidence-based responses are generated from an integrated database, including literature summaries, within specified timeframes. Drug information inquiries are addressed through concise evidence overviews to aid clinical decisions.

InpharmD's top competitors include Omega Therapeutics, CueZen and Fullscript.

InpharmD has 5 investors. Key investors include 645 Ventures, Atlanta Ventures, Y Combinator, Qlarant, and ELC.

Yes. InpharmD publishes InpharmD and 1 more app, with over 100 downloads.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available